SerenQ Retatrutide Pen

SerenQ Retatrutide Pen
SerenQ Pharmaceuticals

SerenQ Retatrutide Pen

Retatrutide · 预充注射笔 · 20mg / 40mg
In Stock 现货 -20% ✓ 批次可追溯 ✓ 第三方 COA 检测
£140.00 – £210.00
In stock · 英国仓现货
🚚 UK 境内配送 · 冷链/避光包装
前往购买 / 询价

In short 产品简述

SerenQ Retatrutide

is the first triple agonist peptide (GLP-1 + GIP + glucagon) supplied in a sealed, pre-filled injection pen. No reconstitution, no bacteriostatic water, no drawing up from vials. Dial the units, read them off the window, dispense.

Specifications 规格参数

含量规格 Content 20mg / 40mg
剂型 Format 预充注射笔
总容量 Total volume 3ml
浓度 Concentration 6.79mg/ml
针头规格 Pen tips 32G 0.23 x 4mm
活性成分 Ingredient Retatrutide
CAS 号 2381089-83-2

About the Product 产品详情

UK Launch · The Ped Shop Exclusive

A triple agonist peptide, pre-dissolved in a graduated pen

SerenQ Pharmaceuticals builds research grade retatrutide into a sealed, pre-filled injection pen rather than a lyophilised vial with a separate bacteriostatic water ampoule. No reconstitution, no working out volumes from a concentration, no drawing up with a syringe barrel. Dial the units, read them off the window, done.

Available in

20mg and 40mg strengths

, both delivered in the same 300 unit pen format so the only variable is concentration per unit. Select your strength above. SerenQ has appointed

The Ped Shop as its exclusive UK stockist

. Every pen sold here comes direct from the manufacturer, in sealed retail cartons, with a unique serial number and QR authenticity code on the label.

Two strengths, one pen format

Choose your strength above

SerenQ Pharmaceuticals

RETATRUTIDE

Triple Agonist · Pre-filled Pen

Content20mg

Dial graduation15u = 1mg

Per unit66.7mcg

Total units300u

FormatPre-filled pen

Pen tips32G 0.23 x 4mm

Expiry12/2027

AuthenticityQR + serial

SerenQ Pharmaceuticals

RETATRUTIDE

Triple Agonist · Pre-filled Pen

Content40mg

Dial graduation15u = 2mg

Per unit133mcg

Total units300u

FormatPre-filled pen

Pen tips32G 0.23 x 4mm

Expiry12/2027

AuthenticityQR + serial

Composition & Dosing Guide

Third Party Testing

Results in

This batch has been independently analysed by

Analiza Białek

in Wrocław. A sealed pen was pulled from production stock and tested by HPLC. These are the figures that came back, and the full certificate is in the gallery above.

20mg pen

Content per ml

6.79mg/ml

Total in pen

20.36mg / 3ml

Label claim

Result

102% of label

Password

C418M3UQ

· order 100017380

40mg pen

Content per ml

13.94mg/ml

Total in pen

41.81mg / 3ml

Label claim

Result

105% of label

Password

A4JU18M3

· order 100017383

Laboratory

Analiza Białek

Method

HPLC

Tested

3 September 2026

Reports

Two, one per strength

Check either report yourself at

using the password shown against that strength.

Serialised & QR Verified

Every SerenQ product carries a unique serial number and a QR code printed on the label. Scan it with any phone camera and you can independently confirm the pen is genuine SerenQ stock and check its batch details before you open the carton.

One code per pen. Each one can only be registered once, so a duplicate scan is an immediate red flag.

You can verify your SerenQ authenticity and view the latest HPLC at

About the compound

Retatrutide

Structurally it is a 39 amino acid peptide, engineered from a GIP backbone with substitutions and a fatty acid moiety attached via a linker for reversible albumin binding. That albumin binding is what carries the plasma half-life out to approximately 6 days, making weekly dosing the operating assumption in the published trials.

Research applications span glycaemic control, body weight and adiposity, appetite regulation, energy expenditure and hepatic lipid handling. Both the 20mg and 40mg pens deliver the same molecule at the same 300 unit graduation, so the only variable across the two is concentration per unit.

Where the evidence sits:

retatrutide is a novel investigational compound currently in Phase III clinical trials.

It is not licensed as a medicinal product in the UK, the US or any other jurisdiction

, has no approved clinical indication, and is not commercially available in any prescription form. It is supplied here strictly as a laboratory research chemical.

The pen format

20mg pen

20mg of retatrutide

per pen, pre-dissolved in solution

1 unit = 66.7mcg

15 units on the dial gives 1mg

300 units in total

, which works out at 20 full 15 unit draws per pen

40mg pen

40mg of retatrutide

per pen, pre-dissolved in solution

1 unit = 133mcg

15 units on the dial gives 2mg

300 units in total

, which works out at 20 full 15 unit draws per pen

Shared across both strengths

– Dial and dose window let you set the exact amount and read it back before dispensing

– 4 screw on pen tips supplied, individually sealed,

32G 0.23 x 4mm

– Protective cap, clip and a rigid retail carton for storage and transport

– Batch number, expiry and serial printed directly on the pen barrel, not just the box

Handling and storage

– Store refrigerated at 2 to 8°C. Do not freeze

– Keep in the outer carton, away from direct light

– Solution should be clear and colourless. Discard if cloudy, discoloured or if particulates are visible

– Short periods at room temperature during transit are expected and normal, though prolonged exposure will degrade potency

– Use a fresh sealed tip for each dispense and dispose of tips in a sharps container

– Expiry 12/2027 on sealed, correctly stored stock

– Keep out of reach of children and animals

What is in the box

– 1 × SerenQ Retatrutide pre-filled injection pen (20mg or 40mg per your selection above)

– 4 × sealed pen tips, 32G 0.23 x 4mm

– Serialised, QR coded retail carton

For research purposes only

This product is sold strictly as a laboratory research chemical.

It is not a medicine, not a supplement and not a cosmetic. It is

not for human or veterinary consumption

, and it is not intended to diagnose, treat, cure or prevent any disease or condition.

Retatrutide is a novel investigational compound in Phase III clinical development.

It is not authorised by the MHRA, the FDA or any other medicines regulator

, has no approved clinical indication, and is not available in any licensed prescription form. Nothing on this page should be read as medical advice, a recommendation, or a suggestion of use in humans or animals.

By purchasing you confirm you are

18 or over

, that you are acquiring this product for legitimate laboratory research or analytical use only, and that you accept full responsibility for its safe handling, storage and lawful use under the regulations that apply where you are.

Third-Party Testing 第三方检测

检测机构 LaboratoryAnaliza Białek
检测方法 MethodHPLC

What's in the Box 包装清单

  • 1 × 预充注射笔
  • 配套密封笔尖(数量以供应商包装为准)

Usage 使用说明

  • 每次使用更换全新密封笔尖
  • 旋拧刻度并核对剂量窗口
  • 按研究方案设定的剂量给药

Handling & Storage 储存条件

  • 2-8°C 冷藏,勿冷冻
  • 避光保存于原包装盒内
  • 首次启用后按供应商建议的期限内使用

Applications 应用方向

Retatrutide 减重代谢 血糖控制

For research purposes only 免责声明

本条目信息整理自公开销售页面(The Ped Shop),仅供研究与信息参考。所列产品按研究用途展示,不作为药品或保健品销售,不用于诊断、治疗、治愈或预防任何疾病。实际规格、价格与库存以供应商页面为准。

UK Launch · The Ped Shop Exclusive

A triple agonist peptide, pre-dissolved in a graduated pen

SerenQ Pharmaceuticals builds research grade retatrutide into a sealed, pre-filled injection pen rather than a lyophilised vial with a separate bacteriostatic water ampoule. No reconstitution, no working out volumes from a concentration, no drawing up with a syringe barrel. Dial the units, read them off the window, done.

Available in

20mg and 40mg strengths

, both delivered in the same 300 unit pen format so the only variable is concentration per unit. Select your strength above. SerenQ has appointed

The Ped Shop as its exclusive UK stockist

. Every pen sold here comes direct from the manufacturer, in sealed retail cartons, with a unique serial number and QR authenticity code on the label.

Two strengths, one pen format

Choose your strength above

SerenQ Pharmaceuticals

RETATRUTIDE

Triple Agonist · Pre-filled Pen

Content20mg

Dial graduation15u = 1mg

Per unit66.7mcg

Total units300u

FormatPre-filled pen

Pen tips32G 0.23 x 4mm

Expiry12/2027

AuthenticityQR + serial

SerenQ Pharmaceuticals

RETATRUTIDE

Triple Agonist · Pre-filled Pen

Content40mg

Dial graduation15u = 2mg

Per unit133mcg

Total units300u

FormatPre-filled pen

Pen tips32G 0.23 x 4mm

Expiry12/2027

AuthenticityQR + serial

Composition & Dosing Guide

Third Party Testing

Results in

This batch has been independently analysed by

Analiza Białek

in Wrocław. A sealed pen was pulled from production stock and tested by HPLC. These are the figures that came back, and the full certificate is in the gallery above.

20mg pen

Content per ml

6.79mg/ml

Total in pen

20.36mg / 3ml

Label claim

Result

102% of label

Password

C418M3UQ

· order 100017380

40mg pen

Content per ml

13.94mg/ml

Total in pen

41.81mg / 3ml

Label claim

Result

105% of label

Password

A4JU18M3

· order 100017383

Laboratory

Analiza Białek

Method

HPLC

Tested

3 September 2026

Reports

Two, one per strength

Check either report yourself at

using the password shown against that strength.

Serialised & QR Verified

Every SerenQ product carries a unique serial number and a QR code printed on the label. Scan it with any phone camera and you can independently confirm the pen is genuine SerenQ stock and check its batch details before you open the carton.

One code per pen. Each one can only be registered once, so a duplicate scan is an immediate red flag.

You can verify your SerenQ authenticity and view the latest HPLC at

About the compound

Retatrutide

Structurally it is a 39 amino acid peptide, engineered from a GIP backbone with substitutions and a fatty acid moiety attached via a linker for reversible albumin binding. That albumin binding is what carries the plasma half-life out to approximately 6 days, making weekly dosing the operating assumption in the published trials.

Research applications span glycaemic control, body weight and adiposity, appetite regulation, energy expenditure and hepatic lipid handling. Both the 20mg and 40mg pens deliver the same molecule at the same 300 unit graduation, so the only variable across the two is concentration per unit.

Where the evidence sits:

retatrutide is a novel investigational compound currently in Phase III clinical trials.

It is not licensed as a medicinal product in the UK, the US or any other jurisdiction

, has no approved clinical indication, and is not commercially available in any prescription form. It is supplied here strictly as a laboratory research chemical.

The pen format

20mg pen

20mg of retatrutide

per pen, pre-dissolved in solution

1 unit = 66.7mcg

15 units on the dial gives 1mg

300 units in total

, which works out at 20 full 15 unit draws per pen

40mg pen

40mg of retatrutide

per pen, pre-dissolved in solution

1 unit = 133mcg

15 units on the dial gives 2mg

300 units in total

, which works out at 20 full 15 unit draws per pen

Shared across both strengths

– Dial and dose window let you set the exact amount and read it back before dispensing

– 4 screw on pen tips supplied, individually sealed,

32G 0.23 x 4mm

– Protective cap, clip and a rigid retail carton for storage and transport

– Batch number, expiry and serial printed directly on the pen barrel, not just the box

Handling and storage

– Store refrigerated at 2 to 8°C. Do not freeze

– Keep in the outer carton, away from direct light

– Solution should be clear and colourless. Discard if cloudy, discoloured or if particulates are visible

– Short periods at room temperature during transit are expected and normal, though prolonged exposure will degrade potency

– Use a fresh sealed tip for each dispense and dispose of tips in a sharps container

– Expiry 12/2027 on sealed, correctly stored stock

– Keep out of reach of children and animals

What is in the box

– 1 × SerenQ Retatrutide pre-filled injection pen (20mg or 40mg per your selection above)

– 4 × sealed pen tips, 32G 0.23 x 4mm

– Serialised, QR coded retail carton

For research purposes only

This product is sold strictly as a laboratory research chemical.

It is not a medicine, not a supplement and not a cosmetic. It is

not for human or veterinary consumption

, and it is not intended to diagnose, treat, cure or prevent any disease or condition.

Retatrutide is a novel investigational compound in Phase III clinical development.

It is not authorised by the MHRA, the FDA or any other medicines regulator

, has no approved clinical indication, and is not available in any licensed prescription form. Nothing on this page should be read as medical advice, a recommendation, or a suggestion of use in humans or animals.

By purchasing you confirm you are

18 or over

, that you are acquiring this product for legitimate laboratory research or analytical use only, and that you accept full responsibility for its safe handling, storage and lawful use under the regulations that apply where you are.

登录

注册

重设密码

请输入您的用户名或电子邮箱地址。您会收到一封包含创建新密码链接的电子邮件。